title: [Case of pneumothorax associated with pulmonary Mycobacterium fortuitum infection].
abstract: A 39-year-old man with dyspnea was revealed to have severe pneumothorax and received partial resection of the left upper lobe after unsuccessful drainage. Necrotizing epitheloid granuloma was found in the resected lung and Mycobacterium fortuitum was detected from the lesion. Chemotherapy with levofloxacin and clarithromycin was started one year after surgery because of the newly found nodular shadow near the lesion. The case experienced pyothorax due to pulmonary tuberculosis three years before and Mycobacterium avium pleuritis one year before this episode. Three-time mycobacterial pleural infection in three years seems to be uncommon. Furthermore this is the first report of pneumothorax associated with pulmonary Mycobacterium fortuitum infection.
authors.affiliation: Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center.
authors.forename: Eri
authors.initials: E
authors.lastname: Hagiwara
authors.forename: Akimasa
authors.initials: A
authors.lastname: Sekine
authors.forename: Tomohide
authors.initials: T
authors.lastname: Sato
authors.forename: Tomohisa
authors.initials: T
authors.lastname: Baba
authors.forename: Takeshi
authors.initials: T
authors.lastname: Shinohara
authors.forename: Takahiro
authors.initials: T
authors.lastname: Endo
authors.forename: Yoko
authors.initials: Y
authors.lastname: Sogo
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Nishihira
authors.forename: Shigeru
authors.initials: S
authors.lastname: Komatsu
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Matsumoto
authors.forename: Takashi
authors.initials: T
authors.lastname: Ogura
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Takahashi
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D017291:Clarithromycin / Q000494:pharmacology / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004322:Drainage; D024881:Drug Resistance, Bacterial; D006801:Humans; D064704:Levofloxacin; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000150:complications* / Q000382:microbiology / Q000628:therapy; D019907:Mycobacterium fortuitum / Q000187:drug effects / Q000302:isolation & purification; D015242:Ofloxacin / Q000494:pharmacology / Q000627:therapeutic use; D011013:Pneumonectomy; D011030:Pneumothorax / Q000209:etiology* / Q000628:therapy; D012008:Recurrence; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000382:microbiology / Q000628:therapy
chemical_list: D000900:Anti-Bacterial Agents; D064704:Levofloxacin; D015242:Ofloxacin; D017291:Clarithromycin